Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Download or print easy-to-read disease leaflets for your patients.
The total annual costs associated with stroke are projected to rise to $240.67 billion by 2030.
Athletes with implantable cardioverter-defibrillators (ICDs) can safely participate in competitive sports.
Sodium and water restriction are unnecessary in patients hospitalized for acute decompensated heart failure (ADHF).
Par Pharmaceuticals announced the launch of Candesartan Cilexetil Tablets, the generic version of AstraZeneca's Atacand.
Treatment with escitalopram reduces mental stress-induced myocardial ischemia (MSIMI) in patients with heart disease and MSIMI.
Social media, email, and other communication technologies have created great opportunities for clinicians to communicate with patients. But being social must be balanced with medical professionalism. MPR investigates.
Despite the commonness and destructive sequelae of stress, Americans are not receiving adequate stress management guidance from their health care providers, according to a recent study.
Statin drugs have been effective in fighting cardiovascular disease and hypercholesterolemia, yet as many as one-fifth of patients discontinue using statins, usually due to adverse events. Is it really necessary for these patients to permanently discontinue statins? MPR investigates.
